Whole-body MRI for the Detection of Metastasis
NCT02183597 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2016-08-10
Summary
Develop and optimize protocols for whole body MRI for detection of metastases. Evaluate diagnostic accuracy through application of optimized protocols for screening of cancer patients.
Conditions
Sponsors & Collaborators
-
Norwegian University of Science and Technology
lead OTHER
Principal Investigators
-
Beathe Sitter, PhD · Norwegian University of Science and Technology
Eligibility
- Min Age
- 18 Years
- Max Age
- 95 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-03-31
- Primary Completion
- 2018-03-31
- Completion
- 2018-03-31
More Related Trials
-
MRI to Detect Breast Tumors in Women
NCT00003302 ·Status: COMPLETED ·Phase: NA
-
Magnetic Resonance Imaging of Breast Cancer
NCT01035112 ·Status: RECRUITING ·Phase: NA
-
Breast MRI for Newly Diagnosed Breast Cancer:Impact on Re-excision Lumpectomy
NCT01568346 ·Status: TERMINATED ·Phase: PHASE3
-
Breast Cancer Screening With Diffusion-weighted MRI in Women at High Risk for Breast Cancer
NCT03835897 ·Status: UNKNOWN
-
Quantitative Methods for Supplementing Contrast-Enhanced Magnetic Resonance Imaging of Breast Cancer
NCT02058758 ·Status: COMPLETED
-
MR Characterisation/Localisation of Breast Cancer
NCT01567137 ·Status: COMPLETED
-
Screening Magnetic Resonance Imaging of the Brain in Patients With Breast Cancer
NCT04030507 ·Status: RECRUITING ·Phase: NA
-
Screening Contralateral Breast Cancers in Patients With Newly Diagnosed Breast Cancer
NCT05307757 ·Status: RECRUITING
-
Abbreviated Breast MRI for Second Breast Cancer Detection in Women With BRCA Mutation Testing
NCT03475979 ·Status: UNKNOWN
-
Using Magnetic Resonance Spectroscopy With MRI to Non-invasively Determine Breast Cancer Extent of Disease
NCT00312637 ·Status: WITHDRAWN ·Phase: NA
-
Contrast Enhanced Spectral Mammography vs. MRI for Breast Cancer Screening
NCT03482557 ·Status: COMPLETED ·Phase: NA
-
Breast MRI Spectroscopy
NCT00577915 ·Status: COMPLETED ·Phase: NA
-
Magnetic Resonance Breast Tissue Characterisation to Improve Risk Stratification for Breast Cancer
NCT03684733 ·Status: COMPLETED
-
Diffusion Weighted Magnetic Resonance Imaging of the Breast During Chemotherapy: Response Evaluation
NCT01684735 ·Status: COMPLETED
-
Breast MRI for Neaodjuvant Chemotherapy Response Prediction and Evaluation in Breast Cancer
NCT03580837 ·Status: UNKNOWN
-
Breast MRI in Evaluation of Pathologic Response in Patients With Breast Cancer With Neoadjuvent Chemotherapy
NCT05301790 ·Status: UNKNOWN
-
PET Study of Breast Cancer Patients Using [68Ga]ABY-025
NCT01858116 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
HER2 PET Imaging in Breast Cancer Patients Using [68GA]ABY-025
NCT02095210 ·Status: TERMINATED ·Phase: PHASE1
-
Low-field MRI for Breast Cancer Screening
NCT05486520 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
MRI and Early Decision-making in Chemotherapy for Breast Cancer
NCT02449824 ·Status: COMPLETED
-
Prospective Ultrafast MRI Radiomics for Breast Cancer
NCT06104189 ·Status: COMPLETED
-
Radiomic Markers for Breast Cancer Metastasis and Treatment Response Using MRI
NCT03709186 ·Status: COMPLETED
-
Abbreviated Breast MRI After Cancer Treatment
NCT03664778 ·Status: COMPLETED
-
Monitoring Response to Neoadjuvant Chemotherapy by the Use of Breast Proton MR Spectroscopy
NCT00580086 ·Status: COMPLETED
-
Magnetic Resonance Imaging (MRI) Correlation to Standard of Care Imaging and Pathology Correlation in Breast Carcinoma
NCT00291304 ·Status: TERMINATED ·Phase: PHASE2